Camtek posts record Q3, guides Q4 ~$127M; GAAP loss on notes
Camtek Ltd. reported record Q3 2025 revenue of $126.0 million, up 12% year over year. GAAP gross profit was $63.0 million (50.0% margin) and non-GAAP gross profit was $64.9 million (51.5%). GAAP operating income reached $31.9 million (25.3% margin), while non-GAAP operating income was $37.6 million (29.9%).
Due to a debt transaction, Camtek recorded an $89 million loss tied to extinguishment of notes, resulting in a GAAP net loss of $53.2 million (−$1.16 per basic share). On a non-GAAP basis, net income was $40.9 million ($0.82 per diluted share), up 10% year over year. The company issued $500 million of 0% convertible senior notes in a private offering and used part of the proceeds to repurchase prior notes; cash, deposits and marketable securities totaled $794.0 million as of September 30, 2025. Management expects Q4 2025 revenue of around $127 million and projects $495 million for 2025, implying 15% growth over 2024.
Positive
- Guides 2025 revenue to $495 million, up 15% vs. 2024
Negative
- GAAP net loss of $53.2 million due to $89 million note extinguishment loss
Insights
Solid growth and strong balance sheet; GAAP loss stems from debt action.
Camtek posted Q3 revenue of
The reported GAAP net loss of
Management guides Q4 revenue around
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
(Translation of Registrant’s Name into English)
P.O. Box 544
Migdal Haemek 23150
ISRAEL
(Address of Principal Corporate Offices)
|
CAMTEK LTD.
(Registrant) By: /s/ Moshe Eisenberg —————————————— Moshe Eisenberg, Chief Financial Officer |
![]() |
Camtek Ltd.
P.O.Box 544, Ramat Gabriel Industrial Park
Migdal Ha’Emek 23150, ISRAEL
Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523
E-Mail: Info@camtek.com Web site: http://www.camtek.com
|
|
CAMTEK LTD.
Moshe Eisenberg, CFO
Tel: +972 4 604 8308
Mobile: +972 54 900 7100
moshee@camtek.com
|
INTERNATIONAL INVESTOR RELATIONS
EK Global Investor Relations
Ehud Helft
Tel: (US) 1 212 378 8040 camtek@ekgir.com
|
| • |
Record revenues of $126.0 million, a 12% YoY increase;
|
| • |
GAAP gross margin of 50.0% and non-GAAP gross margin of 51.5%;
|
| • |
GAAP operating income of $31.8 million (up 8% YoY) and non-GAAP operating income of $37.6 million (up 10% YoY), representing operating margins of 25.3% and 29.9%, respectively;
|
| • |
$500 million raised via new offering of convertible notes;
|
| • |
The GAAP results include a one-time capital loss of $89 million, net, related to the repurchase of 83% of the 2021 convertible notes which led to a GAAP net loss of $53.2 million and EPS of $(1.16); non-GAAP net income of $40.9 million (up
10% YoY); non-GAAP diluted EPS of $0.82; and
|
| • |
Generated cash of over $34 million from operating activities.
|
|
September 30,
|
December 31,
|
|||||||
|
2025
|
2024
|
|||||||
|
U.S. Dollars
|
||||||||
|
Assets
|
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
199,671
|
126,224
|
||||||
|
Short-term deposits
|
382,450
|
231,000
|
||||||
|
Marketable securities
|
57,373
|
30,813
|
||||||
|
Trade accounts receivable, net
|
112,502
|
99,471
|
||||||
|
Inventories
|
126,492
|
111,204
|
||||||
|
Other current assets
|
21,337
|
21,347
|
||||||
|
Total current assets
|
899,825
|
620,059
|
||||||
|
Long-term deposits
|
20,000
|
26,000
|
||||||
|
Marketable securities
|
134,460
|
87,115
|
||||||
|
Long-term inventory
|
16,131
|
11,879
|
||||||
|
Deferred tax asset, net
|
10,858
|
3,090
|
||||||
|
Other assets, net
|
2,493
|
2,001
|
||||||
|
Property, plant and equipment, net
|
62,214
|
54,196
|
||||||
|
Intangible assets, net
|
10,736
|
13,357
|
||||||
|
Goodwill
|
74,345
|
74,345
|
||||||
|
Total non- current assets
|
331,237
|
271,983
|
||||||
|
Total assets
|
1,231,062
|
892,042
|
||||||
|
Liabilities and shareholders’ equity
|
||||||||
|
Current liabilities
|
||||||||
|
Trade accounts payable
|
33,232
|
46,630
|
||||||
|
Other current liabilities
|
85,463
|
77,280
|
||||||
|
Total current liabilities
|
118,695
|
123,910
|
||||||
|
Long-term liabilities
|
||||||||
|
Deferred tax liabilities, net
|
-
|
5,606
|
||||||
|
Other long-term liabilities
|
15,220
|
15,366
|
||||||
|
Convertible notes
|
519,111
|
197,925
|
||||||
|
Total long-term liabilities
|
534,331
|
218,897
|
||||||
|
Total liabilities
|
653,026
|
342,807
|
||||||
|
Commitments and contingencies
|
||||||||
|
Shareholders’ equity
|
||||||||
|
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at September 30, 2025, and at December 31, 2024;
|
||||||||
|
47,858,633 issued shares at September 30, 2025, and 47,541,682 at December 31, 2024;
|
||||||||
|
45,766,257 shares outstanding at September 30, 2025, and 45,449,306 at December 31, 2024
|
178
|
177
|
||||||
|
Additional paid-in capital
|
227,589
|
214,931
|
||||||
|
Accumulated other comprehensive income (loss)
|
1,520
|
203
|
||||||
|
Retained earnings
|
350,647
|
335,822
|
||||||
|
579,934
|
551,133
|
|||||||
|
Treasury stock, at cost (2,092,376 shares as of September 30, 2025, and December 31, 2024)
|
(1,898
|
)
|
(1,898
|
)
|
||||
|
Total shareholders' equity
|
578,036
|
549,235
|
||||||
|
Total liabilities and shareholders' equity
|
1,231,062
|
892,042
|
||||||
|
Nine months ended
September 30,
|
Three months
ended September 30,
|
Year ended
December 31,
|
||||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
|
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
|
Revenues
|
367,948
|
311,941
|
125,993
|
112,340
|
429,234
|
|||||||||||||||
|
Cost of revenues
|
181,731
|
160,122
|
62,951
|
56,484
|
219,283
|
|||||||||||||||
|
Gross profit
|
186,217
|
151,819
|
63,042
|
55,856
|
209,951
|
|||||||||||||||
|
Operating expenses:
|
||||||||||||||||||||
|
Research and development
|
35,289
|
27,916
|
13,453
|
9,770
|
38,287
|
|||||||||||||||
|
Selling, general and administrative
|
54,409
|
47,134
|
17,744
|
16,440
|
63,595
|
|||||||||||||||
|
Total operating expenses
|
89,698
|
75,050
|
31,197
|
26,210
|
101,882
|
|||||||||||||||
|
Operating income
|
96,519
|
76,769
|
31,845
|
29,646
|
108,069
|
|||||||||||||||
|
Financial income, net
|
16,901
|
16,994
|
6,526
|
6,370
|
23,169
|
|||||||||||||||
|
Other expenses
|
(100,932
|
)
|
-
|
(100,932
|
)
|
-
|
-
|
|||||||||||||
|
Income (loss) before income taxes
|
12,488
|
93,763
|
(62,561
|
)
|
36,016
|
131,238
|
||||||||||||||
|
Income tax benefit (expense)
|
2,337
|
(8,257
|
)
|
9,380
|
(3,273
|
)
|
(12,723
|
)
|
||||||||||||
|
Net income (loss)
|
14,825
|
85,506
|
(53,181
|
)
|
32,743
|
118,515
|
||||||||||||||
|
Earnings per share information:
|
Nine months ended
September 30,
|
Three months
ended September 30,
|
Year ended
December 31,
|
|||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
|
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
|
Basic net earnings (loss) per share (in US dollars)
|
0.32
|
1.89
|
(1.16
|
)
|
0.72
|
2.62
|
||||||||||||||
|
Diluted net earnings (loss) per share (in US dollars)
|
0.32
|
1.73
|
(1.16
|
)
|
0.66
|
2.42
|
||||||||||||||
|
Weighted average number of
|
||||||||||||||||||||
|
ordinary shares outstanding:
|
||||||||||||||||||||
|
Basic
|
45,655
|
45,176
|
45,755
|
45,365
|
45,279
|
|||||||||||||||
|
Diluted
|
49,502
|
49,333
|
45,755
|
49,437
|
49,369
|
|||||||||||||||
|
Nine Months ended
September 30,
|
Three Months ended
September 30,
|
Year ended
December 31,
|
||||||||||||||||||
| 2025 |
2024
|
2025 |
2024
|
2024
|
||||||||||||||||
|
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
|
Reported net income attributable to Camtek Ltd. on GAAP basis
|
14,825
|
85,506
|
(53,181
|
)
|
32,743
|
118,515
|
||||||||||||||
|
Acquisition of FRT-related expenses (1)
|
2,268
|
4,684
|
968
|
650
|
5,334
|
|||||||||||||||
|
Loss from extinguishment of Capital Notes (2)
|
88,682
|
-
|
88,682
|
-
|
-
|
|||||||||||||||
|
Share-based compensation
|
12,586
|
10,723
|
4,383
|
3,614
|
14,775
|
|||||||||||||||
|
Non-GAAP net income
|
118,361
|
100,913
|
40,852
|
37,007
|
138,624
|
|||||||||||||||
|
Non–GAAP net income per diluted share
|
2.42
|
2.05
|
0.82
|
0.75
|
2.83
|
|||||||||||||||
|
Gross margin on GAAP basis
|
50.6
|
%
|
48.7
|
%
|
50.0
|
%
|
49.7
|
%
|
49.6
|
%
|
||||||||||
|
Reported gross profit on GAAP basis
|
186,217
|
151,819
|
63,042
|
55,856
|
209,951
|
|||||||||||||||
|
Acquisition of FRT-related expenses (1)
|
2,285
|
5,192
|
1,065
|
610
|
5,802
|
|||||||||||||||
|
Share-based compensation
|
2,094
|
1,602
|
750
|
596
|
2,197
|
|||||||||||||||
|
Non- GAAP gross profit
|
190,596
|
158,613
|
64,857
|
57,062
|
217,950
|
|||||||||||||||
|
Non-GAAP gross margin
|
51.8
|
%
|
50.8
|
%
|
51.5
|
%
|
50.8
|
%
|
50.8
|
%
|
||||||||||
|
Reported operating income attributable to Camtek Ltd. on GAAP basis
|
96,519
|
76,769
|
31,845
|
29,646
|
108,069
|
|||||||||||||||
|
Acquisition of FRT related expenses (1)
|
3,239
|
6,527
|
1,383
|
928
|
7,455
|
|||||||||||||||
|
Share-based compensation
|
12,586
|
10,723
|
4,383
|
3,614
|
14,775
|
|||||||||||||||
|
Non-GAAP operating income
|
112,344
|
94,019
|
37,611
|
34,188
|
130,299
|
|||||||||||||||
